Evolva and Cornelius Group Bring New Fermented Resveratrol to Market

636053014262030135grape.jpg

28 Jul 2016 --- Evolva have announced teaming up with Cornelius Group, an independent European distributor of high quality ingredients, for the marketing of resveratrol in certain European markets. Evolva’s resveratrol is produced via an innovative fermentation process using yeast.

Resveratrol is an ingredient found in red grapes, blueberries, nuts and other plants. There is already a significant body of evidence showing that resveratrol can produce a positive impact on healthy-ageing variables like heart health, bone health, and blood-glucose control. Scientists have also found evidence in key biomarkers that resveratrol might slow the progression of Alzheimer’s disease and mimic the effects of a calorie-restricted diet. Evolva’s resveratrol comes from a fermentation process, producing a high-purity ingredient free of any environmental contaminants.
 
Joy Thomas, technical manager, Cornelius Group said: “Most resveratrol on the market today comes from the Japanese knotweed plant. Evolva’s resveratrol is different and is manufactured via the fermentation of yeast, making it a pure product that is free of pesticides and other impurities that can be found in knotweed extracts.”
 
The fermented resveratrol from Evolva has a purity over 98 per cent and is suitable for a broad range of products from capsules and tablets for dietary supplements to more complex applications in foods, animal nutrition and personal care products. Cornelius has a strong position in these application markets. As the exclusive distributor for Evolva’s fermented resveratrol, Cornelius will supply the ingredient to the UK, Republic of Ireland, Denmark, Norway, Sweden and Finland foods market, countries with a total population 96 million.
 
Ms Thomas added “Consumers are now demanding formulations derived from natural sources. The clean label trend is now seen more as a consumer expectation, as well as an industry standard. Fermentation of Evolva’s resveratrol is a natural process and supports the current market and consumer trends”.
 
Evolva CEO Neil Goldsmith, said: “Much of the resveratrol sold today is made from knotweed, which results in a lack of control over the standard of crop. The benefit of using the fermentation process is that it ensures the quality of the ingredient. Manufacturing resveratrol through the fermentation of yeast offers us, and our customers, peace of mind as it’s made from natural and sustainable feedstocks and has a stable, traceable and reliable supply chain.”
 
This distribution agreement does not change Evolva’s revenue guidance for 2016.
 
Earlier this year, Evolva announced that the European Patent Office granted the Company patent number 2742142, intellectual property pivotal to the commercial expansion of and broader access to the best-tasting stevia-sweeteners made possible through the introduction of yeast fermentation-derived steviol glycosides. Evolva currently has 54 patents pending around the world related to yeast fermentation-derived steviol glycosides and they now have four commercially relevant stevia sweetener patents granted.

Related Articles

Business News

Glanbia Announces Dairy Ireland Sale, Q1 Total Group Revenue Up

26 Apr 2017 ---  26 April 2017 – Global nutrition group Glanbia released its first quarter results, with Total Group Revenue increasing 9.6% on a reported basis and 7.7% on a constant currency basis. The company has also signed binding transaction agreements with Glanbia Co-operative Society for the sale of a controlling stake in the Dairy Ireland segment and related associate businesses. Currently, Dairy Ireland is a wholly owned segment of Glanbia and comprises two business units, Glanbia Consumer Foods Ireland and Glanbia Agribusiness.

Business News

Novozymes Posts “Positive” Q1 Results with Sales and Earnings “On Track”

26 Apr 2017 --- Denmark-based biotechnology company Novozymes has reported overall positive Q1 results with a 3% organic sales growth mainly driven by food & beverages and bioenergy. The company reports that sales and earnings are on track with this “good start to 2017” which has also seen solid progress on Novozymes strategic priorities. 

Business News

Duas Rodas Invests US$7 Million in Chilean Plant

26 Apr 2017 --- Duas Rodas, a key international company in the manufacture of aromas and ingredients for the food and beverage industries is set to inaugurate new facilities for its factory in Chile. The investment of more than US$7 million is part of the strategy of consolidation and expansion of the Brazilian multinational in the Latin American market.

Business News

NIZO Partners on Center of Excellence for Product & Process Modeling

26 Apr 2017 --- At yesterday’s Advanced Process Modelling Forum Process Systems Enterprise (PSE), the Advanced Process Modelling company, and NIZO, the world’s leading food & nutrition contract research organization, announced the formation of the Center of Excellence (CoE) for Food Product and Process Modelling.

Business News

Nestlé to Cut 300 UK Jobs and Move Blue Riband to Poland

26 Apr 2017 --- Nestlé UK is informing employees of proposals to make some changes to the factory operations within its UK confectionery business. These proposals span four different sites: York, Fawdon, Halifax and Girvan and may result in a reduction of 298 roles, predominantly at York and Fawdon, through 2017 and 2018. The company expects that these would be achieved through voluntary redundancies.

More Articles